Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (531-540 of 666) with videos related to

Pageof 67
Sort By:
Cell Reports|November 12, 2019
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell InfiltrationHye-Jung E Chun, Pascal D Johann, Katy Milne, et al.
Neuropathology and Applied Neurobiology|August 17, 2022
Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour typesAnnekathrin Reinhardt, Kristin Pfister, Daniel Schrimpf, et al.
The Lancet. Oncology|August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour GroupStefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
Acta Neuropathologica|June 29, 2019
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1Philipp Sievers, Romain Appay, Daniel Schrimpf, et al.
Nature|February 21, 2012
Clonal selection drives genetic divergence of metastatic medulloblastomaXiaochong Wu, Paul A Northcott, Adrian Dubuc, et al.
Acta Neuropathologica|November 20, 2020
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosisAbigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Nature Communications|July 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomasRomain Sigaud, Thomas K Albert, Caroline Hess, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Pageof 67

Showing results (531-540 of 666) with videos related to

Sort By:
Pageof 67
Cell Reports|November 12, 2019
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell InfiltrationHye-Jung E Chun, Pascal D Johann, Katy Milne, et al.
Neuropathology and Applied Neurobiology|August 17, 2022
Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour typesAnnekathrin Reinhardt, Kristin Pfister, Daniel Schrimpf, et al.
The Lancet. Oncology|August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour GroupStefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
Acta Neuropathologica|June 29, 2019
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1Philipp Sievers, Romain Appay, Daniel Schrimpf, et al.
Nature|February 21, 2012
Clonal selection drives genetic divergence of metastatic medulloblastomaXiaochong Wu, Paul A Northcott, Adrian Dubuc, et al.
Acta Neuropathologica|November 20, 2020
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosisAbigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Nature Communications|July 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomasRomain Sigaud, Thomas K Albert, Caroline Hess, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Pageof 67